SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: StockDoc who wrote (855)11/10/1998 3:15:00 PM
From: sim1  Read Replies (2) | Respond to of 887
 
FDA Meeting next week.

ONCOLOGIC DRUGS ADVISORY COMMITTEE

DATE AND TIME: Nov. 16, 8:30 a.m.

LOCATION: Holiday Inn, Kennedy Grand Ballroom, 8777 Georgia
Ave., Silver Spring, MD.

CONTACT: Karen M. Templeton-Somers, Center for Drug Evaluation
and Research, 301-827-7001.

The committee will discuss Panretin (alitretinoin), Ligand
Pharmaceuticals Inc., for the treatment of cutaneous lesions in
patients with acquired immune deficiency syndrome(AIDS)-related
Kaposi's sarcoma; and DepoCytTM (cytarabine liposome injection),
DepoTech Corp. for the treatment of lymphomatous meningitis.